Your Navigation:PCAR > Abstract
Search pcar
检索项:
检索词:
Abstract
Pharmaceutical Care and Research: 2017; 17(5):366-369
DOI: 10.5428/pcar20170514
Formulation optimization and in vitro percutaneous penetration of compound phellodendri Chinese cortex fluid
1. PAN YongHua1(1.Department of Pharmacy,Changhai Hospital,Second Military Medical University,Shanghai 200433,China 13661587420@163.com)
2. JIANG Hong2(2. Department of Pharmacy,No. 411 Hospital of PLA,Shanghai 200081,China )
3. CHEN JingXia2(2. Department of Pharmacy,No. 411 Hospital of PLA,Shanghai 200081,China )
4. LIU Wei3(3. Undergraduate of Grade 2011,School of Pharmacy,Bengbu Medical College,Anhui Bengbu 233030,China )
5. WU Gao2(2. Department of Pharmacy,No. 411 Hospital of PLA,Shanghai 200081,China wugao411@163.com)
ABSTRACT  Objective: To study the effects of improved formula of compound phellodendri Chinese cortex fluid on in vitro percutaneous penetration of the drug,so as to provide evidence for formula optimization and production quality control. Methods: With the help of double-chamber penetration unit,optimal percutaneous penetration fluid was screened by using the shaven skin of the rat abdomen as the experimental barrier,and the volume of cumulative penetration of berberine hydrochloriade within the pre-set time was measured as the evaluation indicator by HPLC method. At the same time,percutaneous penetration rates of 3 improved formula preparations were investigated by adding 1% borneol,1% menthanol and 0.5% borneol plus 0.5% menthanol. Results: (1) The linear relationship was good in the range from 0.003 72 μg to 0.023 8 μg for berberine hydrochloride (R2=0.999 8). (2) When 0.9% sodium chloride (normal saline,NS),NS of 20% ethanol,NS of 40% ethanol,20% polyethylene glycol (PEG) were used as the accepted liquid,the cumulative penetration valumes of berberine hydrocholoride in 24 hours were 10.304,7.997,6.551 and 6.074 μg, respectively. Therefore,NS was used as the accepted liquid.(3) The cumulative penetration of berberine hydrochloride of the improved prescriptions in 24 hours by adding 1% borneol or 1% menthanol or 0.5% borneol plus 0.5% menthanol were 14.014,13.291 and 17.895 μg,respectively,which was better than that of original formula (10.304 μg). Conclusion: The percutaneous penetration of the compound phellodendri Chinese cortex fluid of the improved formula was significantly superior to that of the primary formula.
Welcome to PCAR! You are the number 107 reader of this article!
Please cite this article as:
PAN YongHua1,JIANG Hong2,CHEN JingXia2,LIU Wei3,WU Gao2,. Formulation optimization and in vitro percutaneous penetration of compound phellodendri Chinese cortex fluid[J]. Pharmaceutical Care and Research / yao xue fu wu yu yan jiu. 2017; 17(5): 366-369.
References:
1. YAO Jun,ZHAO Xia.Advance in clinical application of compound phellodendron liquid[J]. Chin J New Drugs,2014,23(3):308-312,337.In Chinese with English abstract.
2. HOU Wei,YU Hai,JIAO ShuQing,et al. Application of two kinds of diffusion chamber in percutaneous permeability study[J]. Heilongjiang Med Sci,2002,25(5):66.In Chinese.
3. CHENG LiHui,LU LiXia.Quality criteria research on compound prescription cortex phellodendri Chinensis fluid[J]. Subtrop Plant Sci,2012,41(2):13-18.In Chinese with English abstract.
4. SHI Wei,LIU ZhiQiang,WANG ShuMin,et al. Study on plastics transdermal absorption of berberine hydrochloride of complex prescription Coptis chinensis[J]. Lishizhen Med Mater Med Res,2009,20(11):2696-2697.In Chinese with English abstract.
5. LIU JunHong,WANG Hong,QU PengFei,et al,Methodology of percutaneous absorption in vitro of berberine and effects of other herbs from Jinhuang Cream[J].Chin Tradit Patent Med,2014,36(1):65-69.In Chinese with English abstract.
6. CHEN XiaoE,ZHU WenYuan. Research progress in the mechanism of skin moisturization[J]. Mod Med Health,2011,27(18):2802-2804.In Chinese.
7. WEI ChuRong,WU GanQiu. Research advance in pharmacological effect of borneol and the underlying mechanism[J].Int J Pathol Clin Med,2010,30(5):447-451.In Chinese with English abstract.
《药学服务与研究》杂志社 All Rights Reserved 网站备案号:鲁B2-20061008
·地址:上海市杨浦区长海路168号18号楼东三楼 邮政编码:200433
·联系电话(传真):86-21-65519829, 021-31162330
·电子邮件:PharmCR@vip.163.com
·技术支持:中国康网
管理员入口